Mifepristone improves glycemic control in type 2 diabetes
This study evaluated the effects of mifepristone on glycemic control in type 2 diabetes patients, finding significant improvements in HbA1c levels.
Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study evaluated the effects of mifepristone on glycemic control in type 2 diabetes patients, finding significant improvements in HbA1c levels.
This study evaluated the impact of remote nurse-led patient education on glycemic control in individuals with type 2 diabetes, finding significant improvements in various metabolic markers.
This study evaluated the efficacy and safety of adding a GLP-1 receptor agonist and SGLT2 inhibitor to insulin therapy in Type 1 Diabetes, finding significant improvements in HbA1c and quality of life.
This study investigated the metabolic effects of Metformin and lifestyle modification in early type 2 diabetes management, finding significant benefits from lifestyle changes.
This study evaluated the efficacy and safety of once-weekly tirzepatide in Japanese participants with obesity and type 2 diabetes, showing significant weight loss compared to placebo.
This study reports a case of a 6-year complete remission of type 1 diabetes in an adult following specific interventions.
This study evaluated the feasibility of a mobile health app, Plunde, for promoting lifestyle changes in individuals at risk of Type 2 diabetes. It found significant reductions in body weight and waist circumference among app users.
This randomized controlled trial investigated the effects of incretin-based therapies on insulin clearance in type 2 diabetes. It found significant differences in insulin clearance between treatments.
This study investigated the effects of chronic GIP receptor activation on insulin sensitivity in adults with type 2 diabetes, finding significant improvements in insulin metrics.
The ONWARDS 10 trial evaluated the switch from daily basal insulin to once-weekly insulin icodec, finding improvements in HbA1c and time in range compared to glargine U100.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.